Michelle Burris
Net worth: 236 719 $ as of 31/05/2026
Net worth: 236 719 $ as of 31/05/2026
Michelle Griffin Burris served as a Director at Sonus Pharmaceuticals, Inc. from 2004 to 2008.
She also served as a Director at Polynoma LLC from 2012 to 2014.
Prior to that, she was the Chief Financial Officer & Senior Vice President at Corixa Corp.
from 1994 to 2005, and then at Dendreon Corp.
from 2005 to 2006.
From 2006 to 2009, she served as the Chief Financial Officer, Treasurer & SVP at Emergent Product Development Seattle.
She was also the Executive Vice President-Operations at OncoGenex Pharmaceuticals, Inc. from 2013 to 2013.
Additionally, she served as a Director at Virginia Mason Medical Center and Virginia Mason Health System.
Ms. Burris received her undergraduate degree from George Mason University and her MBA from Seattle University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Adaptive Biotechnologies Corp.
Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine 0.01% | 25/06/2026 | 15,625 ( 0.01% ) | 236 719 $ | 31/05/2026 |
| Companies | Position | End |
|---|---|---|
Polynoma LLC
Polynoma LLC Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company that develops a novel vaccine for the adjuvant treatment of stage IIB and IIC melanoma | Director/Board Member | 01/01/2014 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Director of Finance/CFO | 06/02/2013 |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Director of Finance/CFO | 17/11/2009 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and related therapies | Director/Board Member | 22/08/2008 |
| DENDREON CORPORATION | Director of Finance/CFO | 01/01/2006 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and related therapies | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Health Technology |
Virginia Mason Medical Center
Virginia Mason Medical Center Medical/Nursing ServicesHealth Services Provides integrated health services | Health Services |
George Mason University
George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seattle University
Seattle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PhaseRx, Inc.
PhaseRx, Inc. Pharmaceuticals: MajorHealth Technology Manufactures enzyme replacement therapies | Health Technology |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Polynoma LLC
Polynoma LLC Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company that develops a novel vaccine for the adjuvant treatment of stage IIB and IIC melanoma | Health Technology |
Virginia Mason Health System
Virginia Mason Health System Hospital/Nursing ManagementHealth Services Provides medical services | Health Services |
Select your edition
All financial news and data tailored to specific country editions